February 15, 2016 Rentschler appoints new CFO
Laupheim, February 15, 2016 - Rentschler, a leading contract organization for the development and manufacturing of biopharmaceuticals announces the appointment of Stefan Rampf as new Chief Financial Officer (CFO) effective May 1st, 2016.
Stefan Rampf will be responsible for Commercial Management. The 49-year-old has about one decade’s experience as CFO with renowned companies, most recently with ABL Technik Entlackung GmbH, Leutkirch, and, until 2013, with Volvo Financial Services in Frankfurt.
Dr. Nikolaus F. Rentschler: “Stefan Rampf convinces through his excellent expertise and strengthens the Top Management of Rentschler on its successful way. The Supervisory Board and Management Board are very much looking forward to the cooperation.”
Dr. Frank Mathias: “With Stefan Rampf joining Rentschler, the new Management Board will be complete. Together with Thomas Siklosi and the whole Management Team we will continue our close and successful cooperation with our partners and clients and jointly bring the company forward.”
Rentschler Biopharma SE
Dr. Cora Kaiser
Senior Director Corporate Communication